Molecular diagnosis of cytogenetic abnormalities in patients with schizophrenia
Introduction Schizophrenia is a severe and chronic disorder causing significant disability and functional decline. Schizophrenia is a polygenic disease, with about 100 monogenic sites and 11 sites of chromosomal deletions / duplications involved in its pathogenesis identified. It is a pleiotropic d...
Main Authors: | M. Bar Shai, A. Peleg, T. Zalozhin |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2022-06-01
|
Series: | European Psychiatry |
Subjects: | |
Online Access: | https://www.cambridge.org/core/product/identifier/S0924933822007349/type/journal_article |
Similar Items
-
Clinical and molecular cytogenetic findings and pregnancy outcomes of fetuses with isochromosome Y
by: Yiqun He, et al.
Published: (2022-08-01) -
Comparison of olanzapine-induced weight gain and metabolism abnormalities between topiramate and vitamin C in patients with schizophrenia: a preliminary study
by: Jinling Zhang, et al.
Published: (2023-05-01) -
Cytogenetic Abnormalities in Myelodysplastic Syndromes: An Overview
by: Mohammad Faizan Zahid, et al.
Published: (2016-12-01) -
The Impact of Antipsychotic Treatment on Neurological Soft Signs in Patients with Predominantly Negative Symptoms of Schizophrenia
by: Cristian Petrescu, et al.
Published: (2022-11-01) -
Comparative Genomic Hybridization to Microarrays in Fetuses with High-Risk Prenatal Indications: Polish Experience with 7400 Pregnancies
by: Katarzyna Kowalczyk, et al.
Published: (2022-04-01)